Results for tag: "Celiac Drug"

The Celiac Drug market is a subset of the Immune Disorders Drugs market, which focuses on treatments for celiac disease. Celiac disease is an autoimmune disorder that affects the digestive system, and is triggered by the ingestion of gluten. Celiac Drugs are designed to reduce the symptoms of the disease, such as abdominal pain, bloating, and diarrhea. These drugs can also help to reduce the risk of long-term complications, such as malnutrition and anemia. Celiac Drugs are typically administered orally, and may include enzyme supplements, probiotics, and other medications. In some cases, a gluten-free diet may be recommended in conjunction with drug therapy. Companies in the Celiac Drug market include AbbVie, Allergan, GlaxoSmithKline, Novartis, and Takeda. Show Less Read more